Safety and immunogenicity of the Vi-DT typhoid conjugate vaccine in healthy volunteers in Nepal: an observer-blind, active-controlled, randomised, non-inferiority, phase 3 trial

Posted on by

Lancet Infectious Diseases
Apr 2022 Volume 22 Number 4p 427-562, e101-e127
https://www.thelancet.com/journals/laninf/issue/current

 

Safety and immunogenicity of the Vi-DT typhoid conjugate vaccine in healthy volunteers in Nepal: an observer-blind, active-controlled, randomised, non-inferiority, phase 3 trial
Ganesh Kumar Rai, et al.